Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States

Research output: Contribution to journalArticle

Abstract

Individuals with autism spectrum disorder (ASD) have higher rates of co-occurring diagnoses and use of psychotropic medication prescriptions than people with other developmental disabilities. Few studies have examined these trends in samples of people with intellectual and developmental disabilities (IDD) with and without ASD. Using a random sample of 11,947 adult IDD service users from 25 states, co-occurring diagnoses and psychotropic medication use were compared for those with and without ASD. Regardless of diagnosis, individuals with ASD had higher percentages of psychotropic medication use. Controlling for co-occurring condition, age, gender, and ID level, a diagnosis of ASD predicted number of medications used. Further research is needed to understand why individuals with ASD are prescribed more medication, more often, than similarly functioning groups of individuals without ASD.

Original languageEnglish (US)
Pages (from-to)2291-2303
Number of pages13
JournalJournal of Autism and Developmental Disorders
Volume49
Issue number6
DOIs
StatePublished - Jun 15 2019

Fingerprint

Developmental Disabilities
Intellectual Disability
Disabled Persons
Autism Spectrum Disorder
Prescriptions
Research

Keywords

  • ASD
  • Autism spectrum disorder
  • Community living
  • ID
  • Intellectual and developmental disabilities
  • National core indicators
  • Psychotropic medications

PubMed: MeSH publication types

  • Journal Article

Cite this

@article{a9e011fd0db64612b21f922907b59224,
title = "Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States",
abstract = "Individuals with autism spectrum disorder (ASD) have higher rates of co-occurring diagnoses and use of psychotropic medication prescriptions than people with other developmental disabilities. Few studies have examined these trends in samples of people with intellectual and developmental disabilities (IDD) with and without ASD. Using a random sample of 11,947 adult IDD service users from 25 states, co-occurring diagnoses and psychotropic medication use were compared for those with and without ASD. Regardless of diagnosis, individuals with ASD had higher percentages of psychotropic medication use. Controlling for co-occurring condition, age, gender, and ID level, a diagnosis of ASD predicted number of medications used. Further research is needed to understand why individuals with ASD are prescribed more medication, more often, than similarly functioning groups of individuals without ASD.",
keywords = "ASD, Autism spectrum disorder, Community living, ID, Intellectual and developmental disabilities, National core indicators, Psychotropic medications",
author = "Esler, {Amy N} and Hewitt, {Amy S} and Hall-Lande, {Jennifer A} and Pettingell, {Sandra L} and James Houseworth",
year = "2019",
month = "6",
day = "15",
doi = "10.1007/s10803-019-03903-7",
language = "English (US)",
volume = "49",
pages = "2291--2303",
journal = "Journal of Autism and Developmental Disorders",
issn = "0162-3257",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States

AU - Esler, Amy N

AU - Hewitt, Amy S

AU - Hall-Lande, Jennifer A

AU - Pettingell, Sandra L

AU - Houseworth, James

PY - 2019/6/15

Y1 - 2019/6/15

N2 - Individuals with autism spectrum disorder (ASD) have higher rates of co-occurring diagnoses and use of psychotropic medication prescriptions than people with other developmental disabilities. Few studies have examined these trends in samples of people with intellectual and developmental disabilities (IDD) with and without ASD. Using a random sample of 11,947 adult IDD service users from 25 states, co-occurring diagnoses and psychotropic medication use were compared for those with and without ASD. Regardless of diagnosis, individuals with ASD had higher percentages of psychotropic medication use. Controlling for co-occurring condition, age, gender, and ID level, a diagnosis of ASD predicted number of medications used. Further research is needed to understand why individuals with ASD are prescribed more medication, more often, than similarly functioning groups of individuals without ASD.

AB - Individuals with autism spectrum disorder (ASD) have higher rates of co-occurring diagnoses and use of psychotropic medication prescriptions than people with other developmental disabilities. Few studies have examined these trends in samples of people with intellectual and developmental disabilities (IDD) with and without ASD. Using a random sample of 11,947 adult IDD service users from 25 states, co-occurring diagnoses and psychotropic medication use were compared for those with and without ASD. Regardless of diagnosis, individuals with ASD had higher percentages of psychotropic medication use. Controlling for co-occurring condition, age, gender, and ID level, a diagnosis of ASD predicted number of medications used. Further research is needed to understand why individuals with ASD are prescribed more medication, more often, than similarly functioning groups of individuals without ASD.

KW - ASD

KW - Autism spectrum disorder

KW - Community living

KW - ID

KW - Intellectual and developmental disabilities

KW - National core indicators

KW - Psychotropic medications

UR - http://www.scopus.com/inward/record.url?scp=85060916786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060916786&partnerID=8YFLogxK

U2 - 10.1007/s10803-019-03903-7

DO - 10.1007/s10803-019-03903-7

M3 - Article

VL - 49

SP - 2291

EP - 2303

JO - Journal of Autism and Developmental Disorders

JF - Journal of Autism and Developmental Disorders

SN - 0162-3257

IS - 6

ER -